The rollout of new, World Health Organization-approved, antigen-based rapid diagnostic tests for COVID-19 in Africa is expected to significantly boost testing capacity.
PixCell Medical has received regulatory approval from the Therapeutic Goods Administration (TGA) for its HemoScreen device, designed to make the most common complete blood count (CBC) test accessible locally when results are needed quickly.
Researchers have developed a graphene oxide-based sensor platform to detect acute infections within minutes.
TearExo is a chemical nanoprocessing technology that detects breast cancer using the exosomes found in small amounts of bodily fluids, such as tears, as biomarkers.
Using direct swab or liquid transfer, the QIAstat-Dx provides results for 20+ respiratory or gastrointestinal pathogens in about 1 h, with less than 1 min of hands-on time.
A newly developed biophotonic system makes it possible to detect, in a non-invasive way and with a very small sample of blood, allergies to antibiotics in less than an hour.
Q-Sera has developed a blood collection tube which rapidly produces high-quality serum for testing. The secret to the company's success? Proteins sourced from the venom of the Australian Coastal Taipan.
Sysmex recently launched the UF-5000 flow cytometry system to measure the formed elements in urine samples.
QIAGEN's Investigator kits rapidly generate DNA profiles from blood, buccal swabs and forensic stains.
A Phase 1 clinical trial has gone seriously awry, with one volunteer now dead and others with serious, possibly irreversible, neurological damage.
The Diatron Group has introduced the Abacus Vet5 five-part differential veterinary haematology analyser and the Diatron Aquila three-part differential human haematology analyser.
Trajan Scientific and Medical has announced the hemaPEN blood collection and storage device. Harnessing the benefits of dried blood spot (DBS) sampling in a portable format, hemaPEN offers precision blood sampling with the click of a button via its familiar pen design.
The spread of bowel cancer can be stopped by targeting dormant bowel cancer cells before they form secondary tumours.
Disease, diabetes and endocrinology are the central focuses at the AACB's 2015 conference, which has the major clinical theme of 'Partnerships in testing'.
In line with the increased focus on the end uses of cannabis, including medicinal use, Southern Cross University is increasing its involvement in cannabis genetics and chemistry research.